Cyclacel Pharmaceuticals' abstracts on cell cycle inhibitor drugs selected for presentation at AACR meeting

Download PDF Copy

Apr 2 2010

NewsGuard 100/100 Score

Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) today announced that six abstracts highlighting translational and preclinical data for Cyclacel's cell cycle inhibitor drugs have been selected for presentation at the American Association of Cancer Research (AACR) Annual Meeting, being held from April 17-21, 2010, in Washington, DC.

The abstracts can be accessed through the AACR website, www.aacr.org. Abstract titles are provided below. Please note that according to AACR policy, all data are embargoed until the time of the beginning of the presentation.

SOURCE Cyclacel Pharmaceuticals, Inc.

Posted in: Medical Science News | Pharmaceutical News

Tags: B Cell, Cancer, Cell, Cell Cycle, Dermatitis, Drugs, Hematology, Leukemia, Lung Cancer, Myeloid Leukemia, Oncology, Pharmaceuticals, Preclinical, Research, T-Cell, Xerostomia

Comments (0)

Download PDF Copy

Suggested Reading

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer

New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer

SCimilarity revolutionizes single-cell data analysis with rapid cross-tissue comparisons

SCimilarity revolutionizes single-cell data analysis with rapid cross-tissue comparisons

Liver cell aging can trigger multi-organ failure

Liver cell aging can trigger multi-organ failure

Researchers discover how mutations disrupt protein splicing and cause disease

Researchers discover how mutations disrupt protein splicing and cause disease

Mapping human biology: Human Cell Atlas leads a new era in precision medicine

Mapping human biology: Human Cell Atlas leads a new era in precision medicine

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Researchers reveal cellular foundations of functional brain networks in humans

Researchers reveal cellular foundations of functional brain networks in humans

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options